Research
Env-specific antibodies promote post-treatment control in SIV-infected macaques
Nature · By Vidisha Singh ·
The Brief
- A Nature Microbiology study, published online 10 November 2026, examines Env-specific antibodies and post-treatment control in SIV-infected macaques.
- The source reports that combining antiretroviral therapy, CD8α lymphocyte depletion and N-803 in SIV-infected rhesus macaques achieved latency reversal but not reservoir reduction.
- Only the article abstract snippet was available, so the study's full methods and results are not covered here.
Why it matters
The study addresses post-treatment control and the viral reservoir in SIV-infected macaques, a model used in HIV cure research. Its finding that latency reversal did not reduce the reservoir is relevant to researchers designing cure strategies.
Who’s affected
- HIV and SIV researchers
- researchers working on HIV cure strategies
- #hiv
- #siv
- #antibodies
- #latency reversal
- #hiv reservoir
- #macaques
Nature Microbiology, Published online: 10 November 2026; doi:10.1038/s41564-026-02426-z Latency reversal, but not reservoir reduction, has been achieved by combining antiretroviral therapy, CD8α lymphocyte depletion and N-803 in SIV-infected rhesus macaques. In this study, after…
Timeline
Study published online in Nature Microbiology
nature.com
Env-specific antibodies promote post-treatment control in SIV-infected macaques